Drug Shortage Report for GALLIUM (GA67) CITRATE INJECTION
| Report ID | 171877 |
| Drug Identification Number | 02327813 |
| Brand name | GALLIUM (GA67) CITRATE INJECTION |
| Common or Proper name | gallium Ga-67 citrate injection |
| Company Name | CURIUM CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALLIUM CITRATE GA 67 |
| Strength(s) | 74MBq |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 6 & 12 mCi |
| ATC code | V09HX |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-10-07 |
| Actual start date | 2022-10-07 |
| Estimated end date | 2022-11-13 |
| Actual end date | 2022-11-13 |
| Shortage status | Resolved |
| Updated date | 2022-11-17 |
| Company comments | Following the discontinuation of Lantheus product, Curium is unable to cover Lantheus market. Due to a cyclotron mechanical issue, Curium was unable to execute production of Ga-67 raw material. As a consequence, Gallium Citrate Ga 67 Injection will not be available for shipment Nov 6-10, 2022. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2022-11-17 | French | Compare |
| v10 | 2022-11-17 | English | Compare |
| v9 | 2022-11-10 | French | Compare |
| v8 | 2022-11-10 | English | Compare |
| v7 | 2022-10-31 | French | Compare |
| v6 | 2022-10-31 | English | Compare |
| v5 | 2022-10-31 | English | Compare |
| v4 | 2022-10-17 | French | Compare |
| v3 | 2022-10-17 | English | Compare |
| v2 | 2022-10-17 | French | Compare |
| v1 | 2022-10-17 | English | Compare |
Showing 1 to 11 of 11